IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LISA A FRALEIGH

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1558478115
CMS profile
1261016
Location
LOGAN, UT

General Payments · PY2018–2024

$7,017.19

  • Reported across 315 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,188.35

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry UT All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,103.49 50
Travel and Lodging $1,084.86 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neuronetics, Inc. $1,831.57 2
Supernus Pharmaceuticals, Inc. $558.02 12
Otsuka America Pharmaceutical, Inc. $183.09 8
Teva Pharmaceuticals USA, Inc. $141.98 7
IRONSHORE PHARMACEUTICALS INC. $107.36 5
Janssen Pharmaceuticals, Inc $78.64 3
ABBVIE INC. $58.24 3
Lundbeck LLC $53.74 3
Corium, Inc. $48.69 2
IDORSIA PHARMACEUTICALS US INC $34.60 2
Takeda Pharmaceuticals U.S.A., Inc. $31.54 1
Noven Therapeutics, LLC $24.83 1
ITI, Inc. $21.91 1
Axsome Therapeutics, Inc. $14.14 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $266.20 33
PY2019 $584.56 55
PY2020 $680.12 45
PY2021 $776.03 51
PY2022 $645.38 37
PY2023 $876.55 43
PY2024 $3,188.35 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.53 01/04/2024 Food and Beverage Undisputed 01/23/2026 1103747859 CMS
ABBVIE INC. $19.24 02/26/2024 Food and Beverage Undisputed 01/23/2026 1103747861 CMS
ABBVIE INC. $18.47 10/03/2024 Food and Beverage Undisputed 01/23/2026 1103747863 CMS
Axsome Therapeutics, Inc. $14.14 04/24/2024 Food and Beverage Undisputed 01/23/2026 1148299408 CMS
Corium, LLC $26.14 02/13/2024 Food and Beverage Undisputed 01/23/2026 1100194052 CMS
Corium, LLC $22.55 04/03/2024 Food and Beverage Undisputed 01/23/2026 1100185135 CMS
IDORSIA PHARMACEUTICALS US INC $14.93 02/27/2024 Food and Beverage Undisputed 01/23/2026 1146769703 CMS
IDORSIA PHARMACEUTICALS US INC $19.67 05/30/2024 Food and Beverage Undisputed 01/23/2026 1146779215 CMS
IRONSHORE PHARMACEUTICALS INC. $15.27 01/03/2024 Food and Beverage Undisputed 01/23/2026 1146285876 CMS
IRONSHORE PHARMACEUTICALS INC. $16.38 03/11/2024 Food and Beverage Undisputed 01/23/2026 1146286154 CMS
IRONSHORE PHARMACEUTICALS INC. $28.89 05/08/2024 Food and Beverage Undisputed 01/23/2026 1146286164 CMS
IRONSHORE PHARMACEUTICALS INC. $23.21 08/13/2024 Food and Beverage Undisputed 01/23/2026 1146317193 CMS
IRONSHORE PHARMACEUTICALS INC. $23.61 10/22/2024 Food and Beverage Undisputed 01/23/2026 1146245811 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.91 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143226209 CMS
Janssen Pharmaceuticals, Inc $39.15 04/10/2024 Food and Beverage Undisputed 01/23/2026 1078219539 CMS
Janssen Pharmaceuticals, Inc $19.78 05/01/2024 Food and Beverage Undisputed 01/23/2026 1078219559 CMS
Janssen Pharmaceuticals, Inc $19.71 08/27/2024 Food and Beverage Undisputed 01/23/2026 1078219491 CMS
Lundbeck LLC $16.71 03/19/2024 Food and Beverage Undisputed 01/23/2026 1145916163 CMS
Lundbeck LLC $15.15 05/15/2024 Food and Beverage Undisputed 01/23/2026 1145916165 CMS
Lundbeck LLC $21.88 09/25/2024 Food and Beverage Undisputed 01/23/2026 1145916167 CMS
Neuronetics, Inc. $746.71 11/15/2024 Food and Beverage Undisputed 01/23/2026 1084839959 CMS
Neuronetics, Inc. $1,084.86 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1084840013 CMS
Noven Therapeutics, LLC $24.83 06/12/2024 Food and Beverage Undisputed 01/23/2026 1084823011 CMS
Otsuka America Pharmaceutical, Inc. $22.99 01/10/2024 Food and Beverage Undisputed 01/23/2026 1118893848 CMS
Otsuka America Pharmaceutical, Inc. $19.18 02/08/2024 Food and Beverage Undisputed 01/23/2026 1118893850 CMS
Otsuka America Pharmaceutical, Inc. $22.56 03/05/2024 Food and Beverage Undisputed 01/23/2026 1118893852 CMS
Otsuka America Pharmaceutical, Inc. $24.81 04/11/2024 Food and Beverage Undisputed 01/23/2026 1118893854 CMS
Otsuka America Pharmaceutical, Inc. $21.36 05/09/2024 Food and Beverage Undisputed 01/23/2026 1118893856 CMS
Otsuka America Pharmaceutical, Inc. $24.45 06/20/2024 Food and Beverage Undisputed 01/23/2026 1118893858 CMS
Otsuka America Pharmaceutical, Inc. $27.81 10/24/2024 Food and Beverage Undisputed 01/23/2026 1118893860 CMS
Otsuka America Pharmaceutical, Inc. $19.93 11/19/2024 Food and Beverage Undisputed 01/23/2026 1118893862 CMS
Supernus Pharmaceuticals, Inc. $292.85 01/02/2024 Food and Beverage Undisputed 01/23/2026 1147857213 CMS
Supernus Pharmaceuticals, Inc. $110.11 01/23/2024 Food and Beverage Undisputed 01/23/2026 1147857211 CMS
Supernus Pharmaceuticals, Inc. $3.20 02/09/2024 Food and Beverage Undisputed 01/23/2026 1147857203 CMS
Supernus Pharmaceuticals, Inc. $19.11 03/31/2024 Food and Beverage Undisputed 01/23/2026 1147790946 CMS
Supernus Pharmaceuticals, Inc. $18.98 05/02/2024 Food and Beverage Undisputed 01/23/2026 1147790941 CMS
Supernus Pharmaceuticals, Inc. $19.65 05/31/2024 Food and Beverage Undisputed 01/23/2026 1147790950 CMS
Supernus Pharmaceuticals, Inc. $20.60 07/01/2024 Food and Beverage Undisputed 01/23/2026 1147790954 CMS
Supernus Pharmaceuticals, Inc. $3.77 08/07/2024 Food and Beverage Undisputed 01/23/2026 1147857205 CMS
Supernus Pharmaceuticals, Inc. $14.21 08/07/2024 Food and Beverage Undisputed 01/23/2026 1147857207 CMS
Supernus Pharmaceuticals, Inc. $24.58 08/20/2024 Food and Beverage Undisputed 01/23/2026 1147857209 CMS
Supernus Pharmaceuticals, Inc. $15.43 11/01/2024 Food and Beverage Undisputed 01/23/2026 1147790932 CMS
Supernus Pharmaceuticals, Inc. $15.53 12/03/2024 Food and Beverage Undisputed 01/23/2026 1147790937 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.54 02/28/2024 Food and Beverage Undisputed 01/23/2026 1137550026 CMS
Teva Pharmaceuticals USA, Inc. $31.63 01/29/2024 Food and Beverage Undisputed 01/23/2026 1151542233 CMS
Teva Pharmaceuticals USA, Inc. $17.02 03/18/2024 Food and Beverage Undisputed 01/23/2026 1151542241 CMS
Teva Pharmaceuticals USA, Inc. $16.29 06/04/2024 Food and Beverage Undisputed 01/23/2026 1151542317 CMS
Teva Pharmaceuticals USA, Inc. $21.34 07/09/2024 Food and Beverage Undisputed 01/23/2026 1151542335 CMS
Teva Pharmaceuticals USA, Inc. $23.54 09/03/2024 Food and Beverage Undisputed 01/23/2026 1151542353 CMS
Teva Pharmaceuticals USA, Inc. $9.06 11/04/2024 Food and Beverage Undisputed 01/23/2026 1151542367 CMS
Teva Pharmaceuticals USA, Inc. $23.10 11/25/2024 Food and Beverage Undisputed 01/23/2026 1151542379 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.